- Home
- CHR vs XRTX Comparison
CHR vs XRTX Comparison
Compare CHR & XRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHR
- XRTX
- Stock Information
- Founded
- CHR 2016
- XRTX 2011
- Country
- CHR China
- XRTX Canada
- Employees
- CHR N/A
- XRTX N/A
- Industry
- CHR EDP Services
- XRTX Pharmaceuticals and Biotechnology
- Sector
- CHR Technology
- XRTX Health Care
- Exchange
- CHR Nasdaq
- XRTX Nasdaq
- Market Cap
- CHR 4.3M
- XRTX 4.4M
- IPO Year
- CHR N/A
- XRTX N/A
- Fundamental
- Price
- CHR $0.05
- XRTX $0.54
- Analyst Decision
- CHR
- XRTX
- Analyst Count
- CHR 0
- XRTX 0
- Target Price
- CHR N/A
- XRTX N/A
- AVG Volume (30 Days)
- CHR 93.9M
- XRTX 362.3K
- Earning Date
- CHR 07-30-2025
- XRTX 11-14-2025
- Dividend Yield
- CHR N/A
- XRTX N/A
- EPS Growth
- CHR N/A
- XRTX N/A
- EPS
- CHR 1.92
- XRTX N/A
- Revenue
- CHR $147,134,000.00
- XRTX N/A
- Revenue This Year
- CHR N/A
- XRTX N/A
- Revenue Next Year
- CHR N/A
- XRTX N/A
- P/E Ratio
- CHR $0.02
- XRTX N/A
- Revenue Growth
- CHR N/A
- XRTX N/A
- 52 Week Low
- CHR $0.04
- XRTX $0.52
- 52 Week High
- CHR $3.45
- XRTX $1.79
- Technical
- Relative Strength Index (RSI)
- CHR 21.81
- XRTX 37.87
- Support Level
- CHR $0.04
- XRTX $0.53
- Resistance Level
- CHR $0.05
- XRTX $0.56
- Average True Range (ATR)
- CHR 0.03
- XRTX 0.05
- MACD
- CHR 0.02
- XRTX -0.00
- Stochastic Oscillator
- CHR 2.08
- XRTX 21.98
About CHR Cheer Holding Inc.
Cheer Holding Inc is a provider of next generation mobile internet infrastructure and platform services in China. It is engaged in building a digital ecosystem that integrates platforms, applications, technology, and industry into a cohesive system, thereby creating a new, open business environment that leverages AI technology. Its portfolio includes various products and services, such as Polaris Intelligent Cloud, CHEERS Telepathy, CHEERS Open Platform, CHEERS Video, CHEERS e-Mall, CheerReal, CheerCar, CheerChat, CHEERS Fresh Group-Buying E-commerce Platform, Digital Innovation Research Institute, CHEERS Livestreaming, variety show series, IP short video matrix, and more.
About XRTX XORTX Therapeutics Inc.
XORTX Therapeutics Inc is a clinical-stage biotechnology company focused on identifying, developing, and potentially commercializing therapies to treat progressive kidney disease modulated by aberrant purine and uric acid metabolism and uric acid metabolism in orphan (rare) disease indications such as ADPKD and T2DN, as well as AKI associated with respiratory virus infection. Its focus is on developing three therapeutic products to slow or reverse the progression of chronic kidney disease, address the immediate need of individuals facing AKI associated with respiratory virus infection, and identify other opportunities where existing and new intellectual property can be leveraged to address health issues.